Stemmera team has 19+ years experience on drug discovery area and have own brand of one-stop-shop solutions for drug discovery and toxicology testing.
It has cutting-edge technologies on drug discovery and texocology testing from human iPSC reprogramming to cardiomyocyte differentiation.
As we know cardiotoxin is crucial parameter in new drug development, as long as new drugs don’t pass the cardiotoxin test, then have to stop the R&D before they move to pre-clinic traial. So Stemmera is a pioneer to combine iPSC techonlogy and AI/ML/Robots/Sensor technology together and apply it in drug discovery and toxicology testing. It will change the game in the filed.
